Neutrophil extracellular traps mediate the crosstalk between plaque microenvironment and unstable carotid plaque formation
The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironm...
Saved in:
Published in | Experimental & molecular medicine Vol. 56; no. 8; pp. 1717 - 1735 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.08.2024
Springer Nature B.V Nature Publishing Group 생화학분자생물학회 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1,
LY86
)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (
LY86
), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques.
NETs influence carotid plaque microenvironment and neovascularization
Atherosclerosis, a disease where arteries get blocked with fat, is a main cause of heart disease and stroke. Predicting which atherosclerotic plaques will cause heart attacks is hard. Researchers analyzed gene data from unstable and stable carotid plaques, focusing on neutrophils and a protein called MD-1. The study involved 30 patients and 10 healthy volunteers to understand how MD-1 and neutrophils contribute to plaque instability. The main finding is that MD-1 could be a biomarker for unstable plaques, offering a new target for therapies to prevent major heart events. This progress in understanding the molecular mechanisms behind plaque instability could lead to better prevention strategies for heart disease. Future research may focus on developing treatments that target MD-1 and neutrophils to stabilize plaques and reduce the risk of heart attacks. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author. |
---|---|
AbstractList | The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. Abstract The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. KCI Citation Count: 4 The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques.NETs influence carotid plaque microenvironment and neovascularizationAtherosclerosis, a disease where arteries get blocked with fat, is a main cause of heart disease and stroke. Predicting which atherosclerotic plaques will cause heart attacks is hard. Researchers analyzed gene data from unstable and stable carotid plaques, focusing on neutrophils and a protein called MD-1. The study involved 30 patients and 10 healthy volunteers to understand how MD-1 and neutrophils contribute to plaque instability. The main finding is that MD-1 could be a biomarker for unstable plaques, offering a new target for therapies to prevent major heart events. This progress in understanding the molecular mechanisms behind plaque instability could lead to better prevention strategies for heart disease. Future research may focus on developing treatments that target MD-1 and neutrophils to stabilize plaques and reduce the risk of heart attacks. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author. The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86 )-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 ( LY86 ), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. NETs influence carotid plaque microenvironment and neovascularization Atherosclerosis, a disease where arteries get blocked with fat, is a main cause of heart disease and stroke. Predicting which atherosclerotic plaques will cause heart attacks is hard. Researchers analyzed gene data from unstable and stable carotid plaques, focusing on neutrophils and a protein called MD-1. The study involved 30 patients and 10 healthy volunteers to understand how MD-1 and neutrophils contribute to plaque instability. The main finding is that MD-1 could be a biomarker for unstable plaques, offering a new target for therapies to prevent major heart events. This progress in understanding the molecular mechanisms behind plaque instability could lead to better prevention strategies for heart disease. Future research may focus on developing treatments that target MD-1 and neutrophils to stabilize plaques and reduce the risk of heart attacks. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author. The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques.The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86)-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 (LY86), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of diverse inflammatory mediators in the circulating bloodstream. However, the underlying mechanisms through which NETs influence the microenvironment of atherosclerotic plaques and contribute to the development of unstable carotid plaques remain largely elusive. The objective of this study was to elucidate the role of myeloid differentiation protein 1 (MD-1, LY86 )-induced NETs underlying the crosstalk between unstable plaque formation and the plaque microenvironment. We employed bioinformatics analysis to identify key genes associated with carotid-unstable plaque, followed by comprehensive validation using various experimental approaches on tissue specimens and plasma samples classified based on pathological characteristics. Patients with carotid-unstable plaques exhibited elevated plasma concentrations of MD-1 ( LY86 ), while patients with stable plaques demonstrated comparatively lower levels. Furthermore, soluble MD-1 was found to induce the formation of NETs through activation of Toll-like receptor signaling pathway. The proliferative and immature vascularization effects of NETs on endothelial cells, as well as their inhibitory impact on cell migration, are directly correlated with the concentration of NETs. Additionally, NETs were found to activate the NF-κB signaling pathway, thereby upregulating ICAM1, VCAM1, MMP14, VEGFA, and IL6 expression in both Human umbilical vein endothelial cells (HUVECs) and HAECs. Subsequently, a significant increase in intraplaque neovascularization by NETs results in poor carotid plaque stability, and NETs in turn stimulate macrophages to produce more MD-1, generating a harmful positive feedback loop. Our findings suggest that soluble MD-1 in the bloodstream triggers the production of NETs through activation of the Toll-like receptor signaling pathway and further indicate NETs mediate a crosstalk between the microenvironment of the carotid plaque and the neovascularization of the intraplaque region. Inhibiting NETs formation or MD-1 secretion may represent a promising strategy to effectively suppress the development of unstable carotid plaques. Atherosclerosis, a disease where arteries get blocked with fat, is a main cause of heart disease and stroke. Predicting which atherosclerotic plaques will cause heart attacks is hard. Researchers analyzed gene data from unstable and stable carotid plaques, focusing on neutrophils and a protein called MD-1. The study involved 30 patients and 10 healthy volunteers to understand how MD-1 and neutrophils contribute to plaque instability. The main finding is that MD-1 could be a biomarker for unstable plaques, offering a new target for therapies to prevent major heart events. This progress in understanding the molecular mechanisms behind plaque instability could lead to better prevention strategies for heart disease. Future research may focus on developing treatments that target MD-1 and neutrophils to stabilize plaques and reduce the risk of heart attacks. This summary was initially drafted using artificial intelligence, then revised and fact-checked by the author. |
Author | Li, Shuijie Hao, Zhongfei Li, Jiaju Zhan, Yongxuan Feng, Yan Wang, Dong Liu, Yang Fu, Qiang Li, Qingbin Li, Yongli Wang, Hongjun Chen, Minghui Li, Ruiyan Liu, Mingli Cao, Yu Jiao, Xinyu |
Author_xml | – sequence: 1 givenname: Yu surname: Cao fullname: Cao, Yu organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 2 givenname: Minghui surname: Chen fullname: Chen, Minghui organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 3 givenname: Xinyu surname: Jiao fullname: Jiao, Xinyu organization: Department of Ultrasound, The Second Affiliated Hospital of Heilongjiang University of Chinese Medicine – sequence: 4 givenname: Shuijie surname: Li fullname: Li, Shuijie organization: Department of Biopharmaceutical Sciences, College of Pharmacy, Harbin Medical University, State Key Laboratory of Frigid Zone Cardiovascular Diseases (SKLFZCD) – sequence: 5 givenname: Dong surname: Wang fullname: Wang, Dong organization: Scientific Research Centre, The Second Affiliated Hospital of Harbin Medical University – sequence: 6 givenname: Yongxuan surname: Zhan fullname: Zhan, Yongxuan organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 7 givenname: Jiaju surname: Li fullname: Li, Jiaju organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 8 givenname: Zhongfei surname: Hao fullname: Hao, Zhongfei organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 9 givenname: Qingbin surname: Li fullname: Li, Qingbin organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 10 givenname: Yang surname: Liu fullname: Liu, Yang organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 11 givenname: Yan surname: Feng fullname: Feng, Yan organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 12 givenname: Ruiyan surname: Li fullname: Li, Ruiyan organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 13 givenname: Hongjun surname: Wang fullname: Wang, Hongjun organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 14 givenname: Mingli surname: Liu fullname: Liu, Mingli email: slester@yeah.net organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University – sequence: 15 givenname: Qiang surname: Fu fullname: Fu, Qiang email: fuqiang19890105@163.com organization: Department of Chinese Formulae, Heilongjiang University of Chinese Medicine – sequence: 16 givenname: Yongli surname: Li fullname: Li, Yongli email: liyongli9999@163.com organization: Department of Neurosurgery, The Second Affiliated Hospital of Harbin Medical University |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39085350$$D View this record in MEDLINE/PubMed https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003114952$$DAccess content in National Research Foundation of Korea (NRF) |
BookMark | eNp9kktv1DAUhSNURB_wB1igSGwQUsCPPJwVqioeI1UgobK27Ph6xlPHHmynPH49nqQtbRfNxpb9nZPre89xceC8g6J4idE7jCh7HzEhXVshUlcIE4ar-klxRFBPqrbG9ODO_rA4jnGLEGnqrn5WHNIesYY26Kj4-xWmFPxuY2wJv1MQA1g7WRHKvN_FcgRlRIIybaAcgo8xCXtZSki_AFy5s-LnBOVo8hW4KxO8G8GlUjhVTi6z0maZCD4ZdQNrH0aRjHfPi6da2AgvrteT4senjxdnX6rzb59XZ6fn1dB0baowk61sBFVSKoqVUICl7hXWRKoWAWZd08haUI2oaBXTuCegyLA_oVj2lJ4UbxdfFzS_HAz3wszr2vPLwE-_X6w4Ri2mTY8zvFpg5cWW74IZRfgzK-YDH9ZchGQGC7xRUAupRN-1qmZCMlYjpFivpaZKsy57fVi8dpPMfRxyZ4Kw90zv3zizyUVdcYxpl2fXZIc31w7B597FxEcT9xMSDvwUOUWs7Zv89Rl9_QDd-im43FhOMUL5cR2tM_Xqbkm3tdwEIgNkAeZhB9C3CEZ8nzq-pI7n1PE5dXzvyh6IBpPmGednGfu4lC7SmP_j1hD-l_2I6h-K9u9X |
CitedBy_id | crossref_primary_10_3389_fendo_2024_1434580 crossref_primary_10_1111_jcmm_70220 crossref_primary_10_1016_j_compbiomed_2025_109844 |
Cites_doi | 10.3858/emm.2008.40.3.332 10.3791/52687 10.1160/TH11-09-0650 10.1093/eurheartj/ehu041 10.1007/s10495-013-0873-z 10.1161/CIRCULATIONAHA.109.866053 10.1016/j.biopha.2022.114000 10.1096/fj.07-094235 10.1161/ATVBAHA.108.179739 10.1161/ATVBAHA.110.211342 10.1016/j.ajhg.2019.03.004 10.1172/JCI84538 10.1161/01.CIR.0000087480.94275.97 10.3390/ijms22020978 10.4049/jimmunol.173.6.3653 10.1097/HCO.0000000000000226 10.1002/jnr.21565 10.5966/sctm.2014-0097 10.4049/jimmunol.1400586 10.4049/jimmunol.161.3.1348 10.1111/j.1744-313X.2007.00711.x 10.1093/eurheartj/ehv044 10.1007/s10741-019-09881-3 10.1038/nri3898 10.1016/j.biomaterials.2011.07.006 10.1161/01.CIR.0000144307.82502.32 10.1189/jlb.1209822 10.1038/ni.1628 10.1038/ni755 10.1161/CIRCRESAHA.116.309692 10.1080/07853890802186913 10.1161/CIRCULATIONAHA.106.652859 10.1038/s42003-019-0662-5 10.1016/S0021-9150(02)00018-7 10.1111/j.1749-6632.1997.tb52011.x 10.1016/j.rvsc.2017.02.026 10.1038/35025203 10.1016/j.jmb.2011.09.020 10.1016/j.intimp.2020.106902 10.1016/j.cell.2020.01.015 10.1182/blood-2014-03-453217 10.1038/ni1198 10.1073/pnas.1004153107 |
ContentType | Journal Article |
Copyright | The Author(s) 2024 corrected publication 2025 2024. The Author(s). The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. The Author(s) 2024 2024 |
Copyright_xml | – notice: The Author(s) 2024 corrected publication 2025 – notice: 2024. The Author(s). – notice: The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: The Author(s) 2024 2024 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS 7X8 5PM DOA ACYCR |
DOI | 10.1038/s12276-024-01281-4 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text Korean Citation Index |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Central China ProQuest Central ProQuest One Applied & Life Sciences ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE CrossRef Publicly Available Content Database MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: Directory of Open Access Journals (DOAJ) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 2092-6413 |
EndPage | 1735 |
ExternalDocumentID | oai_kci_go_kr_ARTI_10613591 oai_doaj_org_article_5de4abda976d48ab88400d89fbf3df87 PMC11372095 39085350 10_1038_s12276_024_01281_4 |
Genre | Journal Article |
GeographicLocations | Beijing China United States--US China |
GeographicLocations_xml | – name: China – name: Beijing China – name: United States--US |
GroupedDBID | --- 0R~ 29G 2WC 5-W 53G 5GY 7X7 87B 88E 8FE 8FH 8FI 8FJ 8JR 9ZL AAJSJ AASML ABUWG ACGFO ACGFS ACPRK ACYCR ADBBV AENEX AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BBNVY BENPR BHPHI BPHCQ BVXVI C1A C6C CCPQU DIK DU5 E3Z EBLON EBS EF. EJD EMOBN F5P FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE LK8 M1P M7P NAO OK1 OVT PHGZM PHGZT PIMPY PPXIY PQGLB PQQKQ PROAC PSQYO RNS RNT RNTTT RPM SNYQT TR2 UKHRP W2D XSB AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7XB 8FK AZQEC DWQXO GNUQQ K9. PJZUB PKEHL PQEST PQUKI PRINS PUEGO 7X8 5PM |
ID | FETCH-LOGICAL-c576t-18b6b5a3dbbd31dade1bf9d1f2bd60e18755b4a3f03a6d8f192ed2c4a3f31b933 |
IEDL.DBID | DOA |
ISSN | 2092-6413 1226-3613 |
IngestDate | Thu Jul 31 03:10:23 EDT 2025 Wed Aug 27 01:08:08 EDT 2025 Thu Aug 21 18:35:42 EDT 2025 Thu Jul 10 18:54:41 EDT 2025 Sat Aug 23 12:32:27 EDT 2025 Fri Jul 18 01:41:09 EDT 2025 Thu Jul 24 02:18:04 EDT 2025 Thu Apr 24 23:04:10 EDT 2025 Fri Jul 18 01:12:28 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Language | English |
License | 2024. The Author(s). Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c576t-18b6b5a3dbbd31dade1bf9d1f2bd60e18755b4a3f03a6d8f192ed2c4a3f31b933 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://doaj.org/article/5de4abda976d48ab88400d89fbf3df87 |
PMID | 39085350 |
PQID | 3100359734 |
PQPubID | 2041975 |
PageCount | 19 |
ParticipantIDs | nrf_kci_oai_kci_go_kr_ARTI_10613591 doaj_primary_oai_doaj_org_article_5de4abda976d48ab88400d89fbf3df87 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11372095 proquest_miscellaneous_3086955559 proquest_journals_3100359734 pubmed_primary_39085350 crossref_primary_10_1038_s12276_024_01281_4 crossref_citationtrail_10_1038_s12276_024_01281_4 springer_journals_10_1038_s12276_024_01281_4 |
PublicationCentury | 2000 |
PublicationDate | 20240800 2024-08-01 2024-Aug 20240801 2024-08 |
PublicationDateYYYYMMDD | 2024-08-01 |
PublicationDate_xml | – month: 8 year: 2024 text: 20240800 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: United States – name: Seoul |
PublicationTitle | Experimental & molecular medicine |
PublicationTitleAbbrev | Exp Mol Med |
PublicationTitleAlternate | Exp Mol Med |
PublicationYear | 2024 |
Publisher | Nature Publishing Group UK Springer Nature B.V Nature Publishing Group 생화학분자생물학회 |
Publisher_xml | – name: Nature Publishing Group UK – name: Springer Nature B.V – name: Nature Publishing Group – name: 생화학분자생물학회 |
References | D Marlevi (1281_CR4) 2020; 10 S Lau (1281_CR34) 2021; 22 JK Lovett (1281_CR17) 2004; 110 R Arroyo (1281_CR19) 2019; 2 JY Wang (1281_CR11) 2007; 34 P Scapini (1281_CR23) 2014; 124 Y Doring (1281_CR8) 2017; 120 O Leavy (1281_CR24) 2015; 15 FD Sarno (1281_CR32) 2018; 1990 AJ Lusis (1281_CR2) 2000; 407 L Guo (1281_CR41) 2019; 104 CA Bursill (1281_CR37) 2010; 30 JP Parmar (1281_CR1) 2010; 122 X Jiang (1281_CR25) 2023; 157 S Divanovic (1281_CR26) 2005; 6 HJ Sung (1281_CR46) 2008; 40 C Van der Donckt (1281_CR36) 2015; 36 G Ostermann (1281_CR43) 2002; 3 RT Megens (1281_CR29) 2012; 107 PK Bhavsar (1281_CR38) 2008; 22 M Naghavi (1281_CR13) 2002; 164 J Xu (1281_CR44) 2008; 9 M Naghavi (1281_CR3) 2003; 108 SI Yoon (1281_CR28) 2010; 107 K Luo (1281_CR5) 2011; 32 C Acosta (1281_CR12) 2008; 86 E Kristóf (1281_CR45) 2013; 18 AV Finn (1281_CR31) 2010; 30 K Yuan (1281_CR16) 2020; 88 EA Osborn (1281_CR15) 2015; 30 K Miyake (1281_CR10) 1998; 161 1281_CR18 H Domev (1281_CR21) 2014; 3 DF Barber (1281_CR42) 2004; 173 OE Sørensen (1281_CR7) 2016; 126 C Zuchi (1281_CR20) 2020; 25 D Ribatti (1281_CR14) 2008; 40 T Quillard (1281_CR30) 2015; 36 U Ohto (1281_CR39) 2011; 413 S Wei (1281_CR40) 2010; 88 F Hayashi (1281_CR9) 2003; 102 A Osvaldova (1281_CR27) 2017; 114 JE Deanfield (1281_CR22) 2007; 115 L Barrientos (1281_CR6) 2014; 193 J Kalucka (1281_CR35) 2020; 180 K Sueishi (1281_CR33) 1997; 811 40670645 - Exp Mol Med. 2025 Jul 16. doi: 10.1038/s12276-025-01479-0. |
References_xml | – volume: 40 start-page: 332 year: 2008 ident: 1281_CR46 publication-title: Exp. Mol. Med. doi: 10.3858/emm.2008.40.3.332 – ident: 1281_CR18 doi: 10.3791/52687 – volume: 107 start-page: 597 year: 2012 ident: 1281_CR29 publication-title: Thromb. Haemost. doi: 10.1160/TH11-09-0650 – volume: 36 start-page: 1049 year: 2015 ident: 1281_CR36 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehu041 – volume: 1990 start-page: 020 year: 2018 ident: 1281_CR32 publication-title: AIP Conf. Proc. – volume: 18 start-page: 1235 year: 2013 ident: 1281_CR45 publication-title: Apoptosis doi: 10.1007/s10495-013-0873-z – volume: 122 start-page: 2031 year: 2010 ident: 1281_CR1 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.866053 – volume: 157 start-page: 114000 year: 2023 ident: 1281_CR25 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2022.114000 – volume: 22 start-page: 1807 year: 2008 ident: 1281_CR38 publication-title: FASEB J. doi: 10.1096/fj.07-094235 – volume: 30 start-page: 1282 year: 2010 ident: 1281_CR31 publication-title: Arterioscler Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.108.179739 – volume: 30 start-page: 1773 year: 2010 ident: 1281_CR37 publication-title: Arterioscler Thromb. Vasc. Biol. doi: 10.1161/ATVBAHA.110.211342 – volume: 104 start-page: 925 year: 2019 ident: 1281_CR41 publication-title: Am. J. Hum. Genet. doi: 10.1016/j.ajhg.2019.03.004 – volume: 126 start-page: 1612 year: 2016 ident: 1281_CR7 publication-title: J. Clin. Investig. doi: 10.1172/JCI84538 – volume: 108 start-page: 1664 year: 2003 ident: 1281_CR3 publication-title: Circulation doi: 10.1161/01.CIR.0000087480.94275.97 – volume: 22 start-page: 978 year: 2021 ident: 1281_CR34 publication-title: Int J. Mol. Sci. doi: 10.3390/ijms22020978 – volume: 10 year: 2020 ident: 1281_CR4 publication-title: Sci. Rep. – volume: 173 start-page: 3653 year: 2004 ident: 1281_CR42 publication-title: J. Immunol. doi: 10.4049/jimmunol.173.6.3653 – volume: 30 start-page: 671 year: 2015 ident: 1281_CR15 publication-title: Curr. Opin. Cardiol. doi: 10.1097/HCO.0000000000000226 – volume: 86 start-page: 1077 year: 2008 ident: 1281_CR12 publication-title: J. Neurosci. Res. doi: 10.1002/jnr.21565 – volume: 3 start-page: 1169 year: 2014 ident: 1281_CR21 publication-title: Stem Cells Transl. Med. doi: 10.5966/sctm.2014-0097 – volume: 193 start-page: 5689 year: 2014 ident: 1281_CR6 publication-title: J. Immunol. doi: 10.4049/jimmunol.1400586 – volume: 161 start-page: 1348 year: 1998 ident: 1281_CR10 publication-title: J. Immunol. doi: 10.4049/jimmunol.161.3.1348 – volume: 34 start-page: 407 year: 2007 ident: 1281_CR11 publication-title: Int J. Immunogenet. doi: 10.1111/j.1744-313X.2007.00711.x – volume: 36 start-page: 1394 year: 2015 ident: 1281_CR30 publication-title: Eur. Heart J. doi: 10.1093/eurheartj/ehv044 – volume: 25 start-page: 21 year: 2020 ident: 1281_CR20 publication-title: Heart Fail Rev. doi: 10.1007/s10741-019-09881-3 – volume: 15 start-page: 526 year: 2015 ident: 1281_CR24 publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3898 – volume: 32 start-page: 7951 year: 2011 ident: 1281_CR5 publication-title: Biomaterials doi: 10.1016/j.biomaterials.2011.07.006 – volume: 110 start-page: 2190 year: 2004 ident: 1281_CR17 publication-title: Circulation doi: 10.1161/01.CIR.0000144307.82502.32 – volume: 88 start-page: 495 year: 2010 ident: 1281_CR40 publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.1209822 – volume: 9 start-page: 880 year: 2008 ident: 1281_CR44 publication-title: Nat. Immunol. doi: 10.1038/ni.1628 – volume: 3 start-page: 151 year: 2002 ident: 1281_CR43 publication-title: Nat. Immunol. doi: 10.1038/ni755 – volume: 120 start-page: 736 year: 2017 ident: 1281_CR8 publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.116.309692 – volume: 40 start-page: 606 year: 2008 ident: 1281_CR14 publication-title: Ann. Med. doi: 10.1080/07853890802186913 – volume: 115 start-page: 1285 year: 2007 ident: 1281_CR22 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.106.652859 – volume: 2 start-page: 470 year: 2019 ident: 1281_CR19 publication-title: Commun. Biol. doi: 10.1038/s42003-019-0662-5 – volume: 164 start-page: 27 year: 2002 ident: 1281_CR13 publication-title: Atherosclerosis doi: 10.1016/S0021-9150(02)00018-7 – volume: 811 start-page: 311 year: 1997 ident: 1281_CR33 publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1997.tb52011.x – volume: 114 start-page: 31 year: 2017 ident: 1281_CR27 publication-title: Res Vet. Sci. doi: 10.1016/j.rvsc.2017.02.026 – volume: 407 start-page: 233 year: 2000 ident: 1281_CR2 publication-title: Nature doi: 10.1038/35025203 – volume: 413 start-page: 815 year: 2011 ident: 1281_CR39 publication-title: J. Mol. Biol. doi: 10.1016/j.jmb.2011.09.020 – volume: 102 start-page: 2660e2669 year: 2003 ident: 1281_CR9 publication-title: Blood – volume: 88 start-page: 106902 year: 2020 ident: 1281_CR16 publication-title: Int Immunopharmacol. doi: 10.1016/j.intimp.2020.106902 – volume: 180 start-page: 764 year: 2020 ident: 1281_CR35 publication-title: Cell doi: 10.1016/j.cell.2020.01.015 – volume: 124 start-page: 710 year: 2014 ident: 1281_CR23 publication-title: Blood doi: 10.1182/blood-2014-03-453217 – volume: 6 start-page: 571 year: 2005 ident: 1281_CR26 publication-title: Nat. Immunol. doi: 10.1038/ni1198 – volume: 107 start-page: 10990 year: 2010 ident: 1281_CR28 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1004153107 – reference: 40670645 - Exp Mol Med. 2025 Jul 16. doi: 10.1038/s12276-025-01479-0. |
SSID | ssj0025474 |
Score | 2.404732 |
Snippet | The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the activation of... Abstract The development of unstable carotid atherosclerotic plaques is associated with the induction of neutrophil extracellular traps (NETs) via the... |
SourceID | nrf doaj pubmedcentral proquest pubmed crossref springer |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1717 |
SubjectTerms | 13 14 38 631/114 631/250 631/337 631/80 Arteries Arteriosclerosis Artificial intelligence Atherosclerosis Bioinformatics Biomedical and Life Sciences Biomedicine Cardiovascular disease Cell activation Cellular Microenvironment Disease prevention Endothelial cells Extracellular Traps - metabolism Female Heart attacks Heart diseases Human Umbilical Vein Endothelial Cells - metabolism Humans Intercellular adhesion molecule 1 Leukocyte migration Leukocytes (neutrophilic) Macrophages Male Medical Biochemistry Microenvironments Molecular Medicine Molecular modelling Neutrophils Neutrophils - immunology Neutrophils - metabolism NF-kappa B - metabolism NF-κB protein Plaque, Atherosclerotic - metabolism Plaque, Atherosclerotic - pathology Plaques Signal Transduction Stem Cells Toll-like receptors Umbilical vein Vascularization 생화학 |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3Nb9MwFLdgSIgLgo2PwEBGIC4QLa7txDmhgZgG0nZiUm-WHTtb1S4paXqAv573XCelfCxSlcqxJSfv2f69b0LelJyZTIgytSBPpFh4O1WVLVL4ZbXMK1syDE4-O89PL8TXqZxGhdsqulUOe2LYqF1boY78CBXRHNAvFx-W31OsGoXW1VhC4za5g6nL0KWrmG4FLilCFmYGECPlcG7FoJmMq6MVNBbofos-GBMFctTOwRTy98Nx03T1v6Dn3x6Uf5hRw-l08oDcj7CSHm_44CG55Zt9cnDcgEh9_YO-pcHRM2jQ98nds2hPPyA_z_2679rl1WxBYZfuDOrx0TGVwv_lioa4kt5TQIk0TBug-pxG3y66XBiYML1Gn77fAuaoaRxdI-y0CxhmurafuaHzGCz5iFycfP726TSN1RjSCmSSPmXK5lYa7qx1nDnjPLN16Vg9sS7PPAPBR1pheJ1xkztVA3T0blJhC2e25Pwx2Wvaxj8l1OSFsPDRs4k1wqDlLq9tJVXl86qQViWEDaTQVUxVjhUzFjqYzLnSG_JpIJ8O5NMiIe_GMctNoo4be39ECo89Mcl2aGi7Sx3XrJbOC2OdAcTmhDJWgTCcOVXWtuauVkVCXgN_6Hk1C-PxftnqeadBFPmiUdYGhmUJORz4R8f9YaW33JyQV-NjWNlIZtP4dg19QNosJVxlQp5s2G2cLy8BKnOZJUTtMOLOC-0-aWZXIXs4Y1iYqJQJeT_w7HZe__9iz25-jefk3iQsJnSNPCR7fbf2LwCu9fZlWJO_ANR-PXI priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Rb9QwDI7GkBAvCDZghYGCQLxARdMkbfI4JqaBtD0xaW9R0qTb6W7tqdd7gF-PnWsLBwOJSlWrxpHc2kns-rNDyBvNmc2E0KkDfyLFjbdTVbkyhTOrZVE5zTA5-ey8OL0QXy7l5Q7Jx1yYCNqPJS3jND2iwz6sWJ6XCJdFzESuwO-5Q-5i6XbU6uPieHKypCjFkByTcXVLv60FKNbph2Wl6erbTMw_kZK_hUvjKnTykDwYzEd6tGH4EdkJzR7ZP4J3aW--0bc0Ajrjn_I9cu9siJvvk-_nYd137fJ6tqAwG3cW_9cjAJXC_XJFY_5IHyhYgzSyDSb5nA4YLrpcWGCY3iB275fEOGobT9doXroFdLNd28_8SDwlRT4mFyefvh6fpsOuC2kFvkefMuUKJy33znnOvPWBuVp7VufOF1lg4OBIJyyvM24Lr2owEYPPK3zCmdOcPyG7TduEA0JtUQoHHz3LnRUWI3RF7SqpqlBUpXQqIWwUhamGkuS4M8bCxNA4V2YjPgPiM1F8RiTk3dRnuSnI8U_qjyjhiRKLaccHbXdlBuUy0gdhnbdgmXmhrFPg9GZe6drV3NeqTMhr0A8zr2axP16vWjPvDLgcnw361FxqlpDDUX_MMA-sDIZPoLHkwMmrqRlGMIrZNqFdAw14lVrCoRPydKNuE79cg0nMZZYQtaWIWy-03dLMrmOVcMZwAyItE_J-1NmffP39iz37P_Ln5H4eBxdCIg_Jbt-twwsw03r3Mo7LH5YQOVw priority: 102 providerName: Springer Nature |
Title | Neutrophil extracellular traps mediate the crosstalk between plaque microenvironment and unstable carotid plaque formation |
URI | https://link.springer.com/article/10.1038/s12276-024-01281-4 https://www.ncbi.nlm.nih.gov/pubmed/39085350 https://www.proquest.com/docview/3100359734 https://www.proquest.com/docview/3086955559 https://pubmed.ncbi.nlm.nih.gov/PMC11372095 https://doaj.org/article/5de4abda976d48ab88400d89fbf3df87 https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART003114952 |
Volume | 56 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Experimental and Molecular Medicine, 2024, 56(0), , pp.1717-1735 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3db9MwELdgSIgXBBsfgVEZgXiBaHFsJ_ZjV20alVYhYFLfLDt2WNUuqdL0YfvrOTtpWfl8IVKUyh_S1XfO3S_3YYTeSkp0wpiMDeCJ2B-8HYvC5DHcScmzwkjik5PPJ9nZBRtP-fTWUV8-JqwrD9wt3BG3jmljNahNy4Q2AhBJYoUsTUltKUIeOei8DZjqoRZnOetTZBIqjlYkTXMfbOsjLlIBqGlHDYVq_aBcqqb8naH5a7zkT07ToItOH6GHvRGJhx3xj9EdV-2jg2EFAPrqGr_DIawzfC_fR_fPe-_5AbqZuHXb1MvL2QLDO7nR_qu9D0PF8Hu5wiGLpHUYbEIcyAbDfI77SC68XGggGF_5CL5b6XFYVxavvZFpFjBNN3U7s5vB29TIJ-ji9OTr6Czuz16IC0AgbUyEyQzX1BpjKbHaOmJKaUmZGpsljgDM4YZpWiZUZ1aUYCg6mxa-hRIjKX2K9qq6cs8R1lnODCx6khrNtPfTZaUpuChcVuTciAiRDStU0Rcm9-djLFRwkFOhOvYpYJ8K7FMsQu-3c5ZdWY6_jj72HN6O9CW1QwMImuoFTf1L0CL0BuRDzYtZmO-f32o1bxQAj4_KI2vKJYnQ4UZ-VP82WCnvRIHOnAIlr7fdsI89m3Xl6jWMAWwpOVwyQs86cdvSSyUYxpQnERI7grjzh3Z7qtllqBVOiD-GSPIIfdjI7A-6_rxiL_7Hir1ED9Kw5Xy45CHaa5u1ewUmXGsG6G4-zQfo3nA4_jKG5_HJ5NNnaB1lo0HYyd8BEwVKcw |
linkProvider | Directory of Open Access Journals |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELemTgJeEGx8BAYY8fEC0eLYSZ0HhDbY1LK1QmiT9mbsONmqdklJW6HxR_E3cucmGeVjb6tUtUpsycmdz7-f785HyMuEMx0IkfgG-ISPhbd9mZquD98gj-LUJAyTkwfDuHcsPp1EJ2vkZ5MLg2GVjU10htqWKe6Rb-NGNAf0y8X76Tcfq0ahd7UpobFUi4Ps4jtQttm7_keQ76sw3N87-tDz66oCfgrYeu4zaWITaW6NsZxZbTNm8sSyPDQ2DjIGAD4yQvM84Dq2MgcIlNkwxSucmQQ3QMHkrwsOVKZD1nf3hp-_tBQvEu7cZwagxuewUtZpOgGX2zO42MWAX4z6CCUwt5Wl0FUMgAWuqPJ_gd2_Yzb_cNy69XD_DrldA1m6s9S8u2QtKzbI5k4BJP78gr6mLrTU7dlvkBuD2oO_SX4Ms8W8KqdnowmFdaHS6DnAUFgK_6cz6jJZ5hkFXErdsIEcjGkdTUanEw0DpucYRfhbih7VhaULBLpmAt10Vc5HtmncpmfeI8fXIqn7pFOURfaQUB13hYGXHoRGC42-wjg3aSTTLE67kZEeYY0oVFofjo41OibKOem5VEvxKRCfcuJTwiNv2j7T5dEgV7beRQm3LfFYb3ehrE5VbSVUZDOhjdWAEa2Q2kig34GVSW5ybnPZ9cgL0A81TkeuP_6elmpcKSA_fYXsHqYI88hWoz-qtkgzdTl_PPK8vQ22BMWsi6xcQBvgt0kEn8QjD5bq1o6XJwDOeRR4RK4o4soDrd4pRmfuvHLGsBRSEnnkbaOzl-P6_xt7dPVjPCM3e0eDQ3XYHx48JrdCN7EwMHOLdObVInsCYHFuntYzlJKv120UfgEpBn2N |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLamIU28INi4ZAww4vICUeM4TpwHhAaj2hireGBS34wdJ1vVLilpKjR-Gr-Oc9ykpVz2tkpVK8eWHJ_j4-_43Ah5nnKmgyhKfQP6hI-Ft32ZmcSHb1CIODMpw-Dkk0F8eBp9HIrhBvnZxcKgW2UnE52gtlWGd-Q9vIjmgH551Ctat4jPB_23028-VpBCS2tXTmPBIsf55XdQ32Zvjg6A1i_CsP_hy_tDv60w4GeAsxufSRMbobk1xnJmtc2ZKVLLitDYOMgZgHlhIs2LgOvYygLgUG7DDFs4MylehoL4v5FwwXCPJcOVsicilwGaAbzxOZyZbcBOwGVvBo0Juv6i_0coQYdbOxRd7QA46sq6-Bfs_dt78w8TrjsZ-7fJrRbS0v0FD94hG3m5TXb2S1DnLy7pS-qcTN3t_TbZOmlt-TvkxyCfN3U1PR9NKCxzrdGGgE6xFP5PZ9TFtDQ5BYRK3bRBTRjT1q-MTicaJkwv0J_wt2A9qktL5wh5zQSG6bpqRrbrvAzUvEtOr4VO98hmWZX5A0J1nEQGFj0IjY40Wg3jwmRCZnmcJcJIj7COFCpr06RjtY6JcuZ6LtWCfArIpxz5VOSRV8sx00WSkCt7v0MKL3tigm_XUNVnqpUXStg80sZqQIs2ktpIUMQDK9PCFNwWMvHIM-APNc5Gbjz-nlVqXCtQg44U6vmwWZhH9jr-Ua1smqnVTvLI0-VjkCpIZl3m1Rz6gKabCvikHrm_YLflfHkKMJ2LwCNyjRHXXmj9STk6d5nLGcOiSKnwyOuOZ1fz-v-K7V79Gk_IFogC9elocPyQ3AzdvkIPzT2y2dTz_BGgxsY8dtuTkq_XLQ9-AYkFgF0 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Neutrophil+extracellular+traps+mediate+the+crosstalk+between+plaque+microenvironment+and+unstable+carotid+plaque+formation&rft.jtitle=Experimental+%26+molecular+medicine&rft.au=Cao%2C+Yu&rft.au=Chen%2C+Minghui&rft.au=Jiao%2C+Xinyu&rft.au=Li%2C+Shuijie&rft.date=2024-08-01&rft.issn=2092-6413&rft.eissn=2092-6413&rft.volume=56&rft.issue=8&rft.spage=1717&rft.epage=1735&rft_id=info:doi/10.1038%2Fs12276-024-01281-4&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s12276_024_01281_4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2092-6413&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2092-6413&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2092-6413&client=summon |